Skip to content

CorMedix CRMD Total Current Liabilities

Total Current Liabilities at other companies

Pfizer logo
PfizerPFE
$34.35B-5.8%
Merck & Co. logo
Merck & Co.MRK
$26.95B+7.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$216.87M+10.2%
ITG
Integer HoldingsITGR
$206.34M0.0%
IAR
Integra LifeSciencesIART
$346.85M-62.2%
Abbott logo
AbbottABT
$18.38B+41.3%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's total current liabilities?
CorMedix (CRMD) reported total current liabilities of $128.78M in Q1 2026.
How has CorMedix's total current liabilities changed year-over-year?
CorMedix's total current liabilities increased by 274.5% year-over-year, from $34.39M to $128.78M.
What is the long-term trend for CorMedix's total current liabilities?
Over 5 years (2020 to 2025), CorMedix's total current liabilities has grown at a 111.1% compound annual growth rate (CAGR), from $4.16M to $174.27M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.